First Citizens Bank & Trust Co. decreased its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 19.5% during the second quarter, Holdings Channel reports. The fund owned 90,164 shares of the healthcare conglomerate’s stock after selling 21,794 shares during the period. UnitedHealth Group accounts for about 1.1% of First Citizens Bank & Trust Co.’s portfolio, making the stock its 14th largest position. First Citizens Bank & Trust Co.’s holdings in UnitedHealth Group were worth $12,731,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in UNH. Benjamin F. Edwards & Company Inc. raised its stake in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the last quarter. Evanson Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth $201,000. Parametrica Management Ltd acquired a new stake in shares of UnitedHealth Group during the second quarter worth $201,000. Franklin Street Advisors Inc. NC acquired a new stake in shares of UnitedHealth Group during the second quarter worth $208,000. Finally, Financial Architects Inc raised its stake in shares of UnitedHealth Group by 23.0% in the second quarter. Financial Architects Inc now owns 1,558 shares of the healthcare conglomerate’s stock worth $220,000 after buying an additional 291 shares during the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded down 2.25% during midday trading on Tuesday, hitting $134.98. 1,618,000 shares of the stock traded hands. The company has a 50-day moving average of $137.69 and a 200-day moving average of $136.52. The stock has a market cap of $128.55 billion, a PE ratio of 21.12 and a beta of 0.57. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $144.48.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the consensus estimate of $1.89 by $0.07. The firm had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, equities research analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.81%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
A number of brokerages have recently weighed in on UNH. Leerink Swann restated an “outperform” rating and issued a $165.00 price objective (up from $155.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. FBR & Co restated an “outperform” rating and issued a $155.00 price objective (up from $145.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a report on Friday, July 22nd. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $161.00 price objective (up from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and issued a $155.00 target price (up from $148.00) on shares of UnitedHealth Group in a research note on Wednesday, July 20th. One research analyst has rated the stock with a hold rating, twenty-five have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.65% of the stock is owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.